MedFirst - MedComms

Freelance medical writing services and solutions for the pharmaceutical industry as well as medical, science and healthcare professionals.

[MedFirst - MedComms @MedFirstLtd]

More outbreak patients found as FDA continues to investigate Salmonella infections - Food Safety News https://t.co/p14gpFeaw6 • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Amplia Completes Recruitment for Phase 2 Trial's First 26 - Mirage News https://t.co/ikddtrzn4o • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Loper Bright Could Shift Outlook for FDA Legal Challenges - McDermott Will & Emery https://t.co/pIdm0EaoqF • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

All DOACs recommended for prevention of AF-related stroke, new NICE guideline states - The Pharmaceutical Journal https://t.co/8z33SGZoUn • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

EU signs off on Regeneron and Sanofi's Dupixent for COPD - FiercePharma https://t.co/XoAecjQmC0 • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Cuban Academy of Sciences awards scientific research prizes - https://t.co/DeWyZvkysw https://t.co/ZYXl6BHrKd • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Media Advisory: Minister of State Holder to Highlight Support for Scientific Research at the University of Winnipeg - Yahoo News UK https://t.co/9jpomMFrqo • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

EU approves Sanofi's Dupixent for 'smoker's lungs' - ETHealthWorld https://t.co/k3tZg9GRz6 • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Delta-Fly Pharma Inc.: Notice of initiation of patients enrollment in Phase III Pivotal comparative clinical trial of DFP-14323 - Business Wire https://t.co/LgwuIu4h9G • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Salmonella outbreak in cucumbers sickened 450 people, tied to untreated water in Florida - KATV https://t.co/YaELEHVRgO • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Update on pioneering initiative on regulation and evaluation of digital mental health technologies - https://t.co/r0J33Fg4QD https://t.co/e0CQEgoFcL • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Carmel woman hopeful after participating in clinical trial for Alzheimer's drug - WRTV Indianapolis https://t.co/eZdeFG3FMH • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Europe's CHMP recommends against masitinib authorization - ALS News Today https://t.co/VufrQRO9lZ • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

How the Chevron doctrine’s overturn could effect public health, FDA - The Washington Post https://t.co/gO8iNRk846 • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

NHSE and NICE invite comments on pathway to fast-track MedTech - Digital Health https://t.co/xPHu1IRkUC • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

New England Research & Management Inc. Takes Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - Defense World https://t.co/2HuouEu7gD • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

New Crew Launches to Space Station to Continue Scientific Research - NASA https://t.co/3n4kDGmTc2 • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

CAR-T Therapies May Be Linked to Secondary Tumors - Medscape https://t.co/a4yyPQZzth • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine ... - GlobeNewswire https://t.co/CFbdQLknSf • https://t.co/le73xfx4Lb

[MedFirst - MedComms @MedFirstLtd]

Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk ... - 뉴스와이어 https://t.co/xbdJZfuA1q • https://t.co/le73xfx4Lb